Phosphodiesterase 10A inhibitor PF-2545920 as a prospective agent for the clinical promotion of sperm motility

Phosphodiesterase (PDE) inhibitors can improve sperm motility in patients with asthenozoospermia. However, the most commonly reported nonselective PDE inhibitor pentoxifylline and PDE5 inhibitor sildenafil have the disadvantages of requiring a high concentration and destroying sperm integrity. We ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yi-Ting, Yan, Bin, Li, Yu-Hua, Guo, Li-Na, Wang, Wei-Wei, Liu, Li-Jie, Yu, He-Guo, Diao, Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10521960/
https://www.ncbi.nlm.nih.gov/pubmed/37026191
http://dx.doi.org/10.4103/aja2022117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10521960/
https://www.ncbi.nlm.nih.gov/pubmed/37026191
http://dx.doi.org/10.4103/aja2022117

Ejemplares similares